Cutaneous<i>Mycobacterium haemophilum</i>infection in a patient receiving infliximab for psoriasis

Aamir Aslam; R.L. Green; Luisa Motta; M. Ghrew; Christopher Em Griffiths; Richard B. Warren

doi:10.1111/j.1365-2133.2012.11164.x

Related publications

Article2013

Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis

Amy Foulkes, Lily Wheeler, David Gosal, Christopher Em Griffiths, Richard B. Warren

Article2019

Infliximab and risk of serious infection in patients with psoriasis

Zenas Z N Yiu, Darren M. Ashcroft, Ian Evans, Kathleen McElhone, Mark Lunt, Catherine Smith, Shernaz Walton, Ruth Murphy, NJ Reynolds, A.D. Ormerod, Christopher Em Griffiths, Richard B. Warren

Article2006

Infliximab for the treatment of psoriasis

C. Elise Kleyn, Christopher Em Griffiths

Article2018

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy

Zenas Z N Yiu, Christina Sorbe, Mark Lunt, Stephan Jeff Rustenbach, L Kühl, Matthias Augustin, K.J. Mason, Darren M. Ashcroft, Christopher Em Griffiths, Richard B. Warren, Anthony D. Ormerod, Juliet N. Barker, Ian Evans, Kathleen McElhone, Catherine Smith, Nick J. Reynolds, Ruth Murphy, Marilyn Benham, A. David Burden, Sagair Hussain, Brian Kirby, Linda Lawson,

Article2021

Tender facial nodules in a man receiving adalimumab for psoriasis

Firas C. Kreeshan, Lynne Jamieson, Christopher Em Griffiths